ASCO GUIDELINES Bundle

Ovarian Masses and Treatment of Epithelial Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475493

Contents of this Issue

Navigation

Page 36 of 37

37 Best supportive care Patients with platinum- refractory recurrent ovarian cancer Single agent non- platinum chemotherapy with or without biologic agent (bevacizumab) Single-agent non- platinum chemotherapy or best supportive care OR refer to higher-level cancer center Early referral to palliative care where available Clinicians should offer palliative care, including cancer pain and symptom management, to all patients diagnosed with ovarian cancer Patients with tumor-marker positive (CA-125) only recurrent ovarian cancer No systemic treatment is recommended for tumor marker-positive (CA-125) only recurrent ovarian cancer in the absence of symptoms Basic Limited Enhanced Patient Category Intervention Category Key

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Ovarian Masses and Treatment of Epithelial Ovarian Cancer